Mostafa Cheraghi1, Hassan Ahmadvand2,3, Ali Maleki1, Esmaeel Babaeenezhad4, Salman Shakiba5, Fatemeh Hassanzadeh5. 1. Department of Cardiology, Madani Heart Center, Lorestan University of Medical Sciences, Khorramabad, Iran. 2. Razi Herbal Medicine Research Center, Faculty of Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran. 3. Department of Biochemistry, Faculty of Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran. 4. Department of Clinical Biochemistry, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran. 5. Student Research Committee, Lorestan University of Medical Sciences, Khorramabad, Iran.
Abstract
BACKGROUND: Oxidative stress plays an important role in the development of atherosclerosis. An association exists between the alterations of liver markers and the risk of coronary heart disease (CHD). This study was designed to investigate the status of oxidative stress and liver markers in patients with CHD. METHODS: This study included 50 CHD patients and 50 healthy volunteers. Serum activities of glutathione peroxidase (GPX), catalase (CAT), alkaline phosphatase (ALP), alanine aminotransferase (ALT), aspartate aminotransferase (AST), and glutathione (GSH), malondialdehyde (MDA), nitric oxide (NO), and fasting blood sugar (FBS) concentrations were measured. The Unpaired Student's t-test was used to analyze the data. RESULTS: Serum GSH level and CAT and GPX activities were significantly greater in healthy controls than in CHD patients. Serum MDA, NO, and FBS levels and GGT, ALT, ALP activities were significantly greater in CHD patients than in healthy controls. Serum AST activity was greater in CHD patients than in controls, but the difference was not statistically significant. CONCLUSION: Our results indicate that CHD is related to oxidative stress, lipid peroxidation, inflammation, and elevated liver enzyme activity. CHD is a deadly disease that requires appropriate medical care. Antioxidant treatment might inhibit disease progression.
BACKGROUND: Oxidative stress plays an important role in the development of atherosclerosis. An association exists between the alterations of liver markers and the risk of coronary heart disease (CHD). This study was designed to investigate the status of oxidative stress and liver markers in patients with CHD. METHODS: This study included 50 CHD patients and 50 healthy volunteers. Serum activities of glutathione peroxidase (GPX), catalase (CAT), alkaline phosphatase (ALP), alanine aminotransferase (ALT), aspartate aminotransferase (AST), and glutathione (GSH), malondialdehyde (MDA), nitric oxide (NO), and fasting blood sugar (FBS) concentrations were measured. The Unpaired Student's t-test was used to analyze the data. RESULTS: Serum GSH level and CAT and GPX activities were significantly greater in healthy controls than in CHD patients. Serum MDA, NO, and FBS levels and GGT, ALT, ALP activities were significantly greater in CHD patients than in healthy controls. Serum AST activity was greater in CHD patients than in controls, but the difference was not statistically significant. CONCLUSION: Our results indicate that CHD is related to oxidative stress, lipid peroxidation, inflammation, and elevated liver enzyme activity. CHD is a deadly disease that requires appropriate medical care. Antioxidant treatment might inhibit disease progression.
Authors: V Cavalca; G Cighetti; F Bamonti; A Loaldi; L Bortone; C Novembrino; M De Franceschi; R Belardinelli; M D Guazzi Journal: Clin Chem Date: 2001-05 Impact factor: 8.327
Authors: Rik P Bogers; Wanda J E Bemelmans; Rudolf T Hoogenveen; Hendriek C Boshuizen; Mark Woodward; Paul Knekt; Rob M van Dam; Frank B Hu; Tommy L S Visscher; Alessandro Menotti; Roland J Thorpe; Konrad Jamrozik; Susanna Calling; Bjørn Heine Strand; Martin J Shipley Journal: Arch Intern Med Date: 2007-09-10
Authors: Roger K Schindhelm; Jacqueline M Dekker; Giel Nijpels; Lex M Bouter; Coen D A Stehouwer; Robert J Heine; Michaela Diamant Journal: Atherosclerosis Date: 2006-05-08 Impact factor: 5.162
Authors: Stefan Blankenberg; Hans J Rupprecht; Christoph Bickel; Michael Torzewski; Gerd Hafner; Laurence Tiret; Marek Smieja; François Cambien; Jürgen Meyer; Karl J Lackner Journal: N Engl J Med Date: 2003-10-23 Impact factor: 91.245